EU MDR Vulnerability Management For Medical Devices: Best Practices For Compliance

IBM reports that the average expense associated with a healthcare data breach reached $10.93 million. In the realm of medical devices, the problem is more advanced: vulnerabilities arise from SOUP components, interconnected hardware,unupdated processes, etc., and can cause unauthorised access, data breaches, device malfunctions, or even directly compromise patient safety. To address these risks, the EU MDR mandates cybersecurity as a mandatory requirement for all medical devices, including SBOM-driven oversight, EU MDR Vulnerability Management, and integration with Post-Market Surveillance (PMS), Corrective and Preventive Actions (CAPA), and vigilance reporting.



Understanding what the EU MDR and auditors expect from the manufacturers, where security risks arise, and how manufacturers can implement vulnerability management to protect their devices against advance cyberthreats.

What Does the EU MDR Expect From Medical Device Manufacturers?
The European Union expects manufacturers to treat cybersecurity not as an IT task but as a core component of clinical safety. The EU MDR requires the medical device manufacturers to ensure that their devices are safe, effective, and fit for their intended purpose throughout their entire lifecycle. Manufacturers should integrate risk management and implement cybersecurity measures across the entire lifecycle of the product, and establish a proactive Post-Market Surveillance (PMS) system to monitor for new vulnerabilities.



They should design devices with built-in security controls and regularly identify, assess, and address cybersecurity risks. The manufacturers are expected to ensure devices are designed and manufactured using the “state of the art” to minimise risks from unauthorised access and cyber threats.

What is state of the art?
The state of the art (SOTA) is the currently acknowledged best practices, clinical guidelines, and technological advancements in medicine. It is the regulatory benchmark for the safety and performance of medical devices in the Clinical Evaluation Report (CER).



Source: https://qualysec.com/eu-mdr ...